Everlab

Everlab is a Melbourne, Australia-based health technology company operating a subscription-based preventive care and longevity platform. Members are onboarded digitally and take a battery of diagnostic tests — blood panels tracking 100+ biomarkers, whole-body MRI, DEXA scans, VO2 max, ECG, isometric strength testing, continuous glucose monitoring, CT coronary angiograms, plus genetic and microbiome testing — with results consolidated into a digital health profile that also captures lifestyle and family history data. On top of that data the company layers online doctor consultations, personalised prevention plans and recommended interventions intended to detect disease early and reduce long-term chronic disease risk.

The company describes its product as a "medical operating system" for personalised health, using proprietary AI agents to analyse complex health data, automate clinical summaries and suggest interventions, with the stated aim of reducing the cost of premium personalised care through software leverage. Diagnostics and laboratory work are outsourced to third-party pathology, radiology and specialist partners — more than 1,800 physical locations across Australia as of mid-2026 — while care coordination is brought in-house through an app connected to its clinician network of more than 180 practitioners, including about 90 doctors alongside dieticians and physiotherapists. The company says it pursues findings end-to-end, citing 114 urgent, potentially life-saving findings in 2025.

Founding story

The company grew out of the Melbourne general practice of Dr Steven Lu, who moved from intensive care into general practice after seeing patients' lives shaped by complications of chronic disease and set up a practice aimed at reaching people before they became sick. Sam Kothari, an early Airwallex commercial hire, became a patient after his father had a heart attack at 48 and a close friend's father died of cancer at 52; his extended onboarding, DEXA scan, blood work and strength testing surfaced osteopenia and elevated cardiovascular risk markers. In mid-2023 Kothari and Lu decided to scale the practice and recruited Anshul Jain for technology and Marc Hermann, co-founder of German nutrition brand Foodspring, who had lost his father to a sudden heart attack when Hermann was 13. Everlab was founded in 2023.

Business model

Consumer membership model: individuals pay recurring subscription fees across multiple tiers for a bundled program of diagnostics, monitoring, clinician consultations and personalised prevention plans. Testing capacity is contracted from external pathology, radiology and specialist providers, while the clinical relationship, data platform and care navigation are delivered by Everlab.

Annual/recurring subscription tiers; reported pricing spans roughly A$1,200 to A$3,000 per year depending on tier.

Traction

By mid-2026 the company reported servicing 20,000 patients across more than 40,000 consultations, revenue growth of roughly tenfold in the 11 months following its July 2025 seed round, more than 180 clinicians (including about 90 doctors), integration with more than 1,800 physical testing locations in Australia, and an engineering team grown from fewer than 10 to 25 over six months. At the time of the seed round it reported over 1,000,000 biomarkers processed, with about a quarter of results abnormal and serious conditions uncovered in roughly 2.5% of members, and stated it was on track for 20x growth in 2025.

Latest developments

In June 2026 Everlab announced a $65 million raise at a valuation approaching $500 million, led by Airtree Ventures with participation from Left Lane Capital, Plural, b2venture and angel investors including Australian Test cricket captain Pat Cummins. Funds are directed toward technology and AI development and expansion into the United Kingdom; the founders retained board control.